# Long Term Safety Study of Plecanatide

> **NCT02706483** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 2272 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Plecanatide

## Key facts

- **NCT ID:** NCT02706483
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-06
- **Target enrollment:** 2272 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02706483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02706483, "Long Term Safety Study of Plecanatide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02706483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*